CBD Oil and Capsules for Sleep [Dosing Information] – CBD School

1Irwin, M. R., Olmstead, R., & Carroll, J. E. (2016). Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biological psychiatry80(1), 40–52. https://doi.org/10.1016/j.biopsych.2015.05.014     

2Cooper CBNeufeld EVDolezal BA, et al

Sleep deprivation and obesity in adults: a brief narrative review


3Pellati, F., Borgonetti, V., Brighenti, V., Biagi, M., Benvenuti, S., & Corsi, L. (2018). Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer. BioMed research international2018, 1691428. https://doi.org/10.1155/2018/1691428


4VanDolah, H. J., Bauer, B. A., & Mauck, K. F. (2019). Clinicians’ Guide to Cannabidiol and Hemp Oils. Mayo Clinic proceedings94(9), 1840–1851. https://doi.org/10.1016/j.mayocp.2019.01.003


5Hui-Chen Lu, Ken Mackie, Review of the Endocannabinoid System, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2020, ISSN 2451-9022, https://doi.org/10.1016/j.bpsc.2020.07.016.


6Shannon, S., Lewis, N., Lee, H., & Hughes, S. (2019). Cannabidiol in Anxiety and Sleep: A Large Case Series. The Permanente journal23, 18–041. https://doi.org/10.7812/TPP/18-041


7Suraev AGrunstein RRMarshall NS, et al Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial


8Bachhuber M, Arnsten JH, Wurm G. Use of cannabis to relieve pain and promote sleep by customers at an adult use dispensary. Journal of psychoactive drugs. 2019 Oct 20;51(5):400-4. https://doi.org/10.1080/02791072.2019.1626953


9de Almeida DL, Devi LA. Diversity of molecular targets and signaling pathways for CBD. Pharmacology research & perspectives. 2020 Dec;8(6):e00682. https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.682

10dos Santos R.G., Hallak J.E.C., Crippa J.A.S. (2021) Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review. In: Murillo-Rodriguez E., Pandi-Perumal S.R., Monti J.M. (eds) Cannabinoids and Neuropsychiatric Disorders. Advances in Experimental Medicine and Biology, vol 1264. Springer, Cham. https://doi.org/10.1007/978-3-030-57369-0_3

11Scherma M, Masia P, Satta V, Fratta W, Fadda P, Tanda G. Brain activity of anandamide: a rewarding bliss?. Acta Pharmacologica Sinica. 2019 Mar;40(3):309-23. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6460372/

Source link

You May Also Like